Tag

NASDAQ: GUTS

Zura Bio keeps 2028 cash runway ahead of year‑end tibulizumab data
Adrian Kessler · Oct 27, 2026
Fractyl Health plans 45% job cut to fund Revita FDA submission
Adrian Kessler · Oct 22, 2026